Attached files

file filename
EX-31.1 - EX-31.1 - ACHIEVE LIFE SCIENCES, INC.achv-ex311_8.htm
EX-32.2 - EX-32.2 - ACHIEVE LIFE SCIENCES, INC.achv-ex322_9.htm
EX-32.1 - EX-32.1 - ACHIEVE LIFE SCIENCES, INC.achv-ex321_6.htm
EX-31.2 - EX-31.2 - ACHIEVE LIFE SCIENCES, INC.achv-ex312_10.htm
EX-21.1 - EX-21.1 - ACHIEVE LIFE SCIENCES, INC.achv-ex211_12.htm
EX-10.27 - EX-10.27 - ACHIEVE LIFE SCIENCES, INC.achv-ex1027_925.htm
EX-4.12 - EX-4.12 - ACHIEVE LIFE SCIENCES, INC.achv-ex412_639.htm
10-K - 10-K - ACHIEVE LIFE SCIENCES, INC.achv-10k_20191231.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File Nos. 333-56704, 333-135697, 333-144552, 333-153206, 333-168820, 333-190480, 333-197937, 333-206569, 333-221473, 333-228253 and 333-236059), Form S-1 (File Nos. 333-232817 and 333-228596) and Form S-3 (File Nos. 333-184829, 333-207670 and 333-229019) of Achieve Life Sciences, Inc. of our report dated March 13, 2020 relating to the consolidated financial statements, which appears in this Form 10-K.

 

 

Vancouver, Canada,

 

 

March 13, 2020

 

 

/s/ PricewaterhouseCoopers LLP

Chartered Professional Accountants